Brought to you by 
CircuLite brings in $25mm through its Series B venture round
25 Sep 2020
Executive Summary
CircuLite (developing a chronic heart failure device) has raised $25mm through its Series B venture round. New investor Foundation Medical Partners led and was joined by fellow new participant SB Life Science Ventures and returning backers Forbion Capital Partners (spun out of ABN AMRO) and Oxford Bioscience Partners.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CircuLite brings in $25mm through its Series B venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice